Where FDA breakthrough devices stand through 2025: growth, authorizations, leading specialties, AI trends, and qualification pathways explained.
Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks in the Oval Office of the White House during an event ...
Sentante announced that its Sentante stroke system has been accepted into the FDA Total Product Life Cycle Advisory Program ...
Hosted on MSN
Legal questions swirl around FDA's new expedited drug program, including who should sign off
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results